NMRA
NASDAQ · Pharmaceuticals
Neumora Therapeutics Inc
$0.50
+0.02 (+3.35%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+3,345.3% upside
Low Target
$11.85
Average Target
$17.34
High Target
$21.76
Current Price
$0.50
Current
$0.50
$0.50
Target
$17.34
$17.34
$11.85
$17.34 avg
$21.76
Scenario Analysis
Bear Case
$11.85
2,254.5%
Low target
Base Case
$17.34
+3,345.3%
Avg target
Bull Case
$21.76
+4,223.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.65
-86.2% from high
52-Week Low
$0.32
+59.6% from low
Target vs 52W High
$17.34
+375.1% vs high
Peer Consensus — Pharmaceuticals